Hande Turna

8.7k total citations
51 papers, 448 citations indexed

About

Hande Turna is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Hande Turna has authored 51 papers receiving a total of 448 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Oncology, 18 papers in Pulmonary and Respiratory Medicine and 12 papers in Cancer Research. Recurrent topics in Hande Turna's work include Cancer Immunotherapy and Biomarkers (6 papers), Sarcoma Diagnosis and Treatment (6 papers) and Breast Cancer Treatment Studies (6 papers). Hande Turna is often cited by papers focused on Cancer Immunotherapy and Biomarkers (6 papers), Sarcoma Diagnosis and Treatment (6 papers) and Breast Cancer Treatment Studies (6 papers). Hande Turna collaborates with scholars based in Türkiye, United States and Sweden. Hande Turna's co-authors include Mustafa Özgüroğlu, Ahmet Bılıcı, Nil Molinas Mandel, Süheyla Serdengeçti, Şennur İlvan, Deniz Tural, Fatih Selçukbırıcık, Sergülen Dervişoğlu, Fatih Kantarcı and Didem Çolpan Öksüz and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Scientific Reports.

In The Last Decade

Hande Turna

48 papers receiving 435 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hande Turna Türkiye 12 179 159 93 79 74 51 448
Salvatore Corallo Italy 12 225 1.3× 120 0.8× 47 0.5× 118 1.5× 95 1.3× 37 421
M. L. Maestro Spain 13 171 1.0× 85 0.5× 92 1.0× 44 0.6× 98 1.3× 27 459
Nuriye Özdemir Türkiye 12 214 1.2× 116 0.7× 83 0.9× 85 1.1× 76 1.0× 43 450
Miroslav Podhola Czechia 13 88 0.5× 173 1.1× 73 0.8× 158 2.0× 78 1.1× 38 400
Seisho Sakai Japan 14 190 1.1× 176 1.1× 66 0.7× 103 1.3× 25 0.3× 45 556
Marion Dhooge France 15 208 1.2× 138 0.9× 86 0.9× 145 1.8× 104 1.4× 51 581
Ayşe Ocak Duran Türkiye 11 197 1.1× 119 0.7× 82 0.9× 96 1.2× 29 0.4× 44 439
Tokuhiro Matsubara Japan 14 172 1.0× 92 0.6× 105 1.1× 92 1.2× 31 0.4× 28 510
Zhiqiang Chen China 11 199 1.1× 112 0.7× 106 1.1× 87 1.1× 35 0.5× 45 505
Atsushi Takeshita Japan 13 279 1.6× 140 0.9× 174 1.9× 154 1.9× 72 1.0× 40 580

Countries citing papers authored by Hande Turna

Since Specialization
Citations

This map shows the geographic impact of Hande Turna's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hande Turna with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hande Turna more than expected).

Fields of papers citing papers by Hande Turna

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hande Turna. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hande Turna. The network helps show where Hande Turna may publish in the future.

Co-authorship network of co-authors of Hande Turna

This figure shows the co-authorship network connecting the top 25 collaborators of Hande Turna. A scholar is included among the top collaborators of Hande Turna based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hande Turna. Hande Turna is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Arslanoğlu, İlknur, et al.. (2025). Early Stage Effectiveness of the Automated Insulin Delivery System—Is Artificial Intelligence Really Effective?. Endocrinology research and practice.. 29(2). 101–106.
3.
Sen, G., et al.. (2024). The impact of HER2-low status on pathological complete response and disease-free survival in early-stage breast cancer. BMC Cancer. 24(1). 1311–1311. 1 indexed citations
4.
6.
Turna, Hande, et al.. (2022). The Predictive Importance of Body Mass Index on Response to Neoadjuvant Chemotherapy in Patients with Breast Cancer. Breast Care. 18(1). 42–48. 5 indexed citations
7.
Öztürk, Tülin, Şennur İlvan, Hande Turna, et al.. (2020). Local aromatase activity alterations in breast cancer tissues: A potential way of decision support for clinicians. Experimental and Molecular Pathology. 118. 104574–104574. 1 indexed citations
9.
Turna, Hande, et al.. (2018). Prognostic value of aldehyde dehydrogenase 1 (ALDH1) in invasive breast carcinomas. Bosnian Journal of Basic Medical Sciences. 18(4). 313–319. 5 indexed citations
10.
Yalçın, Şuayib, Ramazan Yıldız, Faysal Dane, et al.. (2018). A national, multicenter, non-interventional, observational study on treatment patterns in patients with metastatic renal cell carcinoma in Turkey – NOTES study. OncoTargets and Therapy. Volume 11. 1223–1228. 2 indexed citations
11.
Turna, Hande, et al.. (2014). Aldehyde dehydrogenase-1 expression and prognosis in triple-negative breast cancer. Medical Science and Discovery. 1(2). 44–44. 2 indexed citations
12.
Öztürk, Mehmet Akif, Fatih Selçukbırıcık, Sinem Nihal Esatoğlu, et al.. (2013). Primary Osteosarcoma of the Heart: Experience of an Unusual Case. Case Reports in Oncology. 6(1). 224–228. 5 indexed citations
13.
Döventaş, Alper, et al.. (2012). Prognostic significance of CD44 and c-erb-B2 protein overexpression in patients with gastric cancer.. PubMed. 59(119). 2196–201. 17 indexed citations
14.
Tural, Deniz, Nil Molinas Mandel, Sergülen Dervişoğlu, et al.. (2012). Extraskeletal Ewing's Sarcoma Family of Tumors in Adults: Prognostic Factors and Clinical Outcome. Japanese Journal of Clinical Oncology. 42(5). 420–426. 54 indexed citations
15.
Turna, Hande, et al.. (2011). Clinicopathologic and prognostic evaluation of invasive breast carcinoma molecular subtypes and GATA3 expression.. PubMed. 15(4). 774–82. 17 indexed citations
16.
Yıldız, Özcan, et al.. (2009). Gastroenteropancreatic neuroendocrine tumors: 10-year experience in a single center. Medical Oncology. 27(4). 1050–1056. 13 indexed citations
17.
Özgüroğlu, Mustafa, Ahmet Bılıcı, Şennur İlvan, et al.. (2008). Determining predominating histologic component in malignant mixed mullerian tumors: is it worth it?. International Journal of Gynecological Cancer. 18(4). 809–812.
18.
Özgüroğlu, Mustafa, et al.. (2006). Devastating effects of chemotherapy: deafness and acute renal failure in a patient with epithelial ovarian cancer. International Journal of Gynecological Cancer. 16(S1). 394–396. 6 indexed citations
19.
Yıldız, Ömer, et al.. (2006). Metastatic primitive neuroectodermal tumor of the ovary in pregnancy. International Journal of Gynecological Cancer. 17(1). 266–269. 19 indexed citations
20.
Özgüroğlu, Mustafa, Hande Turna, Gökhan Demir, et al.. (1999). Usefulness of the Epithelial Tumor Marker CA-125 in Non-Hodgkin’s Lymphoma. American Journal of Clinical Oncology. 22(6). 615–615. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026